Literature DB >> 7717640

Limited role for intraoperative intact PTH measurement in parathyroid surgery.

P Tan1, S H Leveson, H Wilkinson.   

Abstract

Primary hyperparathyroidism may be cured surgically by complete excision of abnormal parathyroid tissue. Reoperation for persistent hypercalcaemia due to residual abnormal parathyroid tissue may be associated with a high complication rate. It is possible to assay intact parathormone (iPTH) intraoperatively and as iPTH has a relatively short half-life, its measurement intraoperatively may be used to predict successful parathyroidectomy. We have studied intraoperative iPTH levels in a consecutive series of 33 patients undergoing surgery for primary hyperparathyroidism. We found that iPTH levels fell significantly (P < 0.05) from a median pre-excision level of 122 pg/ml to a median level of 36 pg/ml 20 min after excision. However, in 3/31 successful parathyroidectomies, the intraoperative iPTH levels either remained unchanged or had risen. Reliance on intraoperative iPTH levels in these patients may have resulted in unnecessary re-exploration. We conclude that intraoperative iPTH measurement has limited usefulness as a predictor of successful parathyroidectomy for primary hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7717640      PMCID: PMC2502514     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  9 in total

1.  Usefulness and limits of quick intraoperative measurements of intact (1-84) parathyroid hormone in the surgical management of hyperparathyroidism: sequential measurements in patients with multiglandular disease.

Authors:  C A Proye; A Goropoulos; C Franz; B Carnaille; M Vix; J L Quievreux; G Couplet-Lebon; A Racadot
Journal:  Surgery       Date:  1991-12       Impact factor: 3.982

2.  Modification to a commercial immunoradiometric assay permitting intraoperative monitoring of parathyroid hormone levels.

Authors:  M F Ryan; S R Jones; A D Barnes
Journal:  Ann Clin Biochem       Date:  1990-01       Impact factor: 2.057

3.  Time to end a conservative treatment for mild hyperparathyroidism.

Authors:  J C Stevenson; J A Lynn
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-09

4.  Intraoperative measurement of parathyroid hormone in the surgical management of hyperparathyroidism.

Authors:  S R Nussbaum; A R Thompson; K A Hutcheson; R D Gaz; C A Wang
Journal:  Surgery       Date:  1988-12       Impact factor: 3.982

5.  Comparison of 'intraoperative' parathormone measurement with frozen section during parathyroid surgery.

Authors:  W Madira; G S Robertson; N J London; S J Iqbal; P R Bell; P S Veitch
Journal:  Ann R Coll Surg Engl       Date:  1993-01       Impact factor: 1.891

6.  Strategy in reoperative surgery for hyperparathyroidism.

Authors:  P S Cheung; A Borgstrom; N W Thompson
Journal:  Arch Surg       Date:  1989-06

Review 7.  Asymptomatic primary hyperparathyroidism.

Authors:  B J Harrison; M H Wheeler
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

8.  Methylene blue for rapid identification of the parathyroids.

Authors:  N E Dudley
Journal:  Br Med J       Date:  1971-09-18

9.  A density test for the intraoperative differentiation of parathyroid hyperplasia from neoplasia.

Authors:  C A Wang; S V Rieder
Journal:  Ann Surg       Date:  1978-01       Impact factor: 12.969

  9 in total
  1 in total

1.  Role of cyclase activating parathyroid hormone (1-84 PTH) measurements during parathyroid surgery: potential improvement of intraoperative PTH assay.

Authors:  Hiroyuki Yamashita; Ping Gao; Shiro Noguchi; Tom Cantor; Shinya Uchino; Shin Watanabe; Hiroto Yamashita; Hitoshi Kawamoto; Masafumi Fukagawa
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.